Nintedanib appears to stabilize lung function in patients with systemic sclerosis-associated ILD exhibiting a PPF phenotype.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results